Decreased Rho GTPase-activating protein 4 (ARHGAP4) facilitates aerobic glycolysis of pancreatic cancer through activating HIF-1α pathway and upregulating M2 isoform of pyruvate kinase (PKM2) expression [31]. Here, HIF1A is linked to pancreatic neoplasm.